Metamizole (dipyrone) is a pyrazolone derivative that belongs to the group of nonacid nonopioids. It is considered a potent analgesic and antipyretic with favourable gastrointestinal tolerability. Metamizole was formerly marketed in the US as Dimethone tablets and injection, Protemp oral liquid, and other drug products, and was withdrawn due to its associati...
Metamizole is banned in several countries, where it was previously used as a powerful analgesic and fever reducer. In countries where it is still available, metamizole is indicated for acute severe pain after injuries or surgeries, colic, tumor pain, and acute or severe pain symptoms, as well as high fever if other treatments are unsuccessful.
Wolfson medical center, Holon, Israel
II Department of Anesthesia and Intensive Care, Medical University of Lublin, Lublin, Poland
Medical University of Silesia, Sosnowiec, Silesia, Poland
Fakultní nemocnice Brno, Brno, Czechia
Szpital Specjalistyczny PRO-FAMILIA w Rzeszowie, Rzeszów, Poland
Szpital Kliniczny Dzieciątka Jezus, Warszawa, Poland
Medical University of Silesia, Sosnowiec, Silesia, Poland
Medical University of Silesia, Sosnowiec, Silesia, Poland
II Department of Anesthesia and Intensive Care, Lublin, Poland
Hadssah Medical Organisation, Jerusalem, Israel
Meander Medical Center, Amersfoort, Netherlands
VU Medical Center, Amsterdam, Netherlands
Academic Medical Center, Amsterdam, Netherlands
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.